HIF1A and breast carcinoma: Consistent with ChIP and luciferase reporter data, CSRP2 and HIF-1α protein levels were significantly correlated in both pre-clinical and patient tumour specimens, supporting that tumour hypoxia is an important determinant of CSRP2 up-regulation in breast cancer.